Skip to content

Erector Spinae Plane Block for Pain Management in Lumbar Percutaneous Vertebroplasty: A Randomized Controlled Trial

Erector Spinae Plane Block for Pain Management in Lumbar Percutaneous Vertebroplasty: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107309
Enrollment
Unknown
Registered
2025-08-08
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

percutaneous vertebro plasty

Interventions

local anaesthesia group:The patient is placed in the prone position. After disinfection, draping, and positioning, the surgeon administers local infiltration anaesthesia using 1% lidocaine.
Erector spinae plane block group:The patient is positioned in a lateral decubitus position. The surgical segment is blocked by an independent nerve block practitioner (with over three years of experie

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age >= 18 years old, ASA 2-3 grade, elective lumbar PVP, PVP involves only a single segment

Exclusion criteria

Exclusion criteria: Pregnancy, allergy to local anaesthetics, coagulation disorders, PVP under general anaesthesia, use of analgesics before surgery, history of chronic pain, mental or neurological disorders, refusal to participate.

Design outcomes

Primary

MeasureTime frame
Incidence of moderate to severe pain during surgery;

Secondary

MeasureTime frame
Intraoperative peak pain score;Intraoperative patient satisfaction with pain relief;Surgeon satisfaction;Incidence of rescue analgesia within 24 hours after surgery;Time of first mobilization;

Countries

China

Contacts

Public ContactAli Li

The First Affiliated Hospital of Henan University of Chinese Medicine

guomingmei@163.com+86 185 3821 5117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026